Patents by Inventor Alan Wickenden

Alan Wickenden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTOXIN-II VARIANTS AND METHODS OF USE THEREOF
    Publication number: 20220054590
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 24, 2022
    Inventors: Mack FLINSPACH, Alan WICKENDEN, Ross FELLOWS, Qinghao XU, Andrew PIEKARZ
  • PROTOXIN-II VARIANTS AND METHODS OF USE
    Publication number: 20210363204
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: May 3, 2021
    Publication date: November 25, 2021
    Inventors: Mack FLINSPACH, Alan WICKENDEN
  • Protoxin-II variants and methods of use
    Patent number: 11083776
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: August 10, 2021
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Mack Flinspach, Alan Wickenden, Ross Fellows, Qinghao Xu, Andrew Piekarz
  • Protoxin-II variants and methods of use
    Patent number: 10995125
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: May 4, 2021
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Mack Flinspach, Alan Wickenden
  • Protoxin-II variants and methods of use
    Patent number: 10975129
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: April 13, 2021
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Mack Flinspach, Alan Wickenden, Ross Fellows, Robert Neff, Yi Liu, Rebecca Hagan, Qinghao Xu
  • PROTOXIN-II VARIANTS AND METHODS OF USE
    Publication number: 20200054712
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: November 4, 2019
    Publication date: February 20, 2020
    Inventors: Mack FLINSPACH, Alan WICKENDEN, Ross FELLOWS, Qinghao XU, Andrew PIEKARZ
  • PROTOXIN-II VARIANTS AND METHODS OF USE
    Publication number: 20200048316
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: April 17, 2017
    Publication date: February 13, 2020
    Inventors: Mack Flinspach, Alan Wickenden, Ross Fellows, Robert Neff, Yi Liu, Rebecca Hagan, Qinghao Xu
  • Protoxin-II variants and methods of use
    Patent number: 10463714
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: November 5, 2019
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Mack Flinspach, Alan Wickenden, Ross Fellows, Qinghao Xu, Andrew Piekarz
  • Huwentoxin-IV variants and methods of use
    Patent number: 10414808
    Abstract: The present invention relates to Huwentoxin-IV variants, polynucleotides encoding them, methods of making and using the foregoing, and methods of alleviating pain with peptide inhibitors of Nav1.7.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: September 17, 2019
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: William Eckert, Mack Flinspach, Michael Hunter, Yi Liu, Robert Neff, Alan Wickenden, Alan Gibbs
  • Kv1.3 Antagonists and Methods of Use
    Publication number: 20190062383
    Abstract: The present invention relates to Kv1.3 antagonists, and polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: September 7, 2018
    Publication date: February 28, 2019
    Inventors: Ellen Chi, Wilson Edwards, Chichi Huang, Wai-Ping Leung, Ronald Swanson, Alan Wickenden
  • Kv1.3 antagonists and methods of use
    Patent number: 10179808
    Abstract: The present invention relates to Kv1.3 antagonists, and polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: January 15, 2019
    Assignee: Janssen Biotech, Inc.
    Inventors: Ellen Chi, Wilson Edwards, Chichi Huang, Wai-Ping Leung, Ronald Swanson, Alan Wickenden
  • PROTOXIN-II VARIANTS AND METHODS OF USE
    Publication number: 20170334959
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: May 1, 2017
    Publication date: November 23, 2017
    Inventors: Mack FLINSPACH, Alan WICKENDEN
  • Protoxin-II variants and methods of use
    Patent number: 9624280
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Grant
    Filed: October 3, 2014
    Date of Patent: April 18, 2017
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Mack Flinspach, Alan Wickenden, Ross Fellows, Robert Neff, Yi Liu, Rebecca Hagan, Qinghao Xu
  • PROTOXIN-II VARIANTS AND METHODS OF USE
    Publication number: 20160287666
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: April 4, 2016
    Publication date: October 6, 2016
    Inventors: Mack Flinspach, Alan Wickenden, Ross Fellows, Qinghao XU, Andrew Piekarz
  • PROTOXIN-II VARIANTS AND METHODS OF USE
    Publication number: 20160257726
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: March 3, 2016
    Publication date: September 8, 2016
    Inventors: Mack FLINSPACH, Alan WICKENDEN
  • SODIUM CHANNEL SENSITIVE CONOPEPTIDES AND ANALOGS, INCLUDING COMPOSITIONS AND METHODS THEREOF
    Publication number: 20150322120
    Abstract: The present invention relates to conopeptides that are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which block the sodium channels.
    Type: Application
    Filed: April 17, 2013
    Publication date: November 12, 2015
    Applicants: University of Utah Research Foundation, Janssen Pharmaceutica NV
    Inventors: Julita Imperial, Brad Reed Green, Joanna Gajewiak, Minmin Zhang, Doju Yoshikami, Grzegorz Bulaj, Baldomero Olivera, Alan Wickenden, Yi Liu
  • Huwentoxin-IV variants and methods of use
    Patent number: 9102751
    Abstract: The present invention relates to Huwentoxin-IV variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: August 11, 2015
    Assignee: JANSSEN BIOTECH, INC.
    Inventors: Mack Flinspach, Michael Hunter, Yi Liu, Robert Neff, Alan Wickenden, Alan Gibbs
  • PROTOXIN -II VARIANTS AND METHODS OF USE
    Publication number: 20150099705
    Abstract: The present invention relates to Protoxin-II variants, polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: October 3, 2014
    Publication date: April 9, 2015
    Inventors: Mack FLINSPACH, Alan Wickenden, Ross Fellows, Robert Neff, Yi Liu, Rebecca Hagan, Qinghao Xu
  • HUWENTOXIN-IV VARIANTS AND METHODS OF USE
    Publication number: 20150087596
    Abstract: The present invention relates to Huwentoxin-IV variants, polynucleotides encoding them, methods of making and using the foregoing, and methods of alleviating pain with peptide inhibitors of Nav1.7.
    Type: Application
    Filed: March 15, 2013
    Publication date: March 26, 2015
    Inventors: William Eckert, Mack Flinspach, Michael Hunter, Yi Liu, Robert Neff, Alan Wickenden, Alan Gibbs
  • Kv1.3 Antagonists and Methods of Use
    Publication number: 20140255401
    Abstract: The present invention relates to Kv1.3 antagonists, and polynucleotides encoding them, and methods of making and using the foregoing.
    Type: Application
    Filed: January 24, 2014
    Publication date: September 11, 2014
    Applicant: Janssen Biotech, Inc.
    Inventors: Ellen Chi, Wilson Edwards, Chichi Huang, Wai-Ping Leung, Ronald Swanson, Alan Wickenden